Pfizer »

AgomAb Therapeutics NV shares owned by Pfizer

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Pfizer from 13F filings

Historical chart of Pfizer investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Pfizer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Pfizer

Quarter filed Position value Share count Share price at filing
2026-03-31 $814k 75k 10.85

More positions owned by Pfizer

Oric Pharmaceuticals (ORIC)
Allogene Therapeutics (ALLO)
Arvinas Ord (ARVN)
Celcuity (CELC)
Zura Bio Class A Ord Shs (ZURA)
Wave Life Sciences SHS (WVE)
Pyxis Oncology Common Stock (PYXS)
Caribou Biosciences (CRBU)
Spero Therapeutics (SPRO)
Biohaven (BHVN)
Cardiff Oncology (CRDF)
Zentalis Pharmaceuticals (ZNTL)
Nextcure Com New (NXTC)
Agomab Therapeutics Nv Ads
Q32 Bio (QTTB)

View all positions for Pfizer

Top funds holding AgomAb Therapeutics NV

Sanofi
Federated Investors
Andera Partners
Standard Life Aberdeen
Seven Grand Managers
Pfizer
Jane Street
UBS Group
SBI Securities

View all funds holding AgomAb Therapeutics NV